Current and historical daily PE Ratio for Nextage Therapeutics Ltd (
XTAE:NXTG
) from 1993 to May 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Nextage Therapeutics stock (XTAE:NXTG) PE ratio as of May 24 2024 is 0.
More Details
Nextage Therapeutics Ltd (XTAE:NXTG) PE Ratio (TTM) Chart
Nextage Therapeutics Ltd (XTAE:NXTG) PE Ratio (TTM) Historical Data
View and export this data going back to 1993. Start your Free Trial
Total 1265
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Nextage Therapeutics PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-24 | At Loss | 2024-03-12 | At Loss |
| 2024-05-23 | At Loss | 2024-03-11 | At Loss |
| 2024-05-22 | At Loss | 2024-03-10 | At Loss |
| 2024-05-21 | At Loss | 2024-03-07 | At Loss |
| 2024-05-20 | At Loss | 2024-03-06 | At Loss |
| 2024-05-19 | At Loss | 2024-03-05 | At Loss |
| 2024-05-16 | At Loss | 2024-03-04 | At Loss |
| 2024-05-15 | At Loss | 2024-03-03 | At Loss |
| 2024-05-12 | At Loss | 2024-02-29 | At Loss |
| 2024-05-09 | At Loss | 2024-02-28 | At Loss |
| 2024-05-08 | At Loss | 2024-02-26 | At Loss |
| 2024-05-07 | At Loss | 2024-02-25 | At Loss |
| 2024-05-06 | At Loss | 2024-02-22 | At Loss |
| 2024-05-05 | At Loss | 2024-02-21 | At Loss |
| 2024-05-02 | At Loss | 2024-02-20 | At Loss |
| 2024-05-01 | At Loss | 2024-02-19 | At Loss |
| 2024-04-30 | At Loss | 2024-02-18 | At Loss |
| 2024-04-25 | At Loss | 2024-02-15 | At Loss |
| 2024-04-24 | At Loss | 2024-02-14 | At Loss |
| 2024-04-21 | At Loss | 2024-02-13 | At Loss |
| 2024-04-18 | At Loss | 2024-02-12 | At Loss |
| 2024-04-17 | At Loss | 2024-02-11 | At Loss |
| 2024-04-16 | At Loss | 2024-02-08 | At Loss |
| 2024-04-15 | At Loss | 2024-02-07 | At Loss |
| 2024-04-14 | At Loss | 2024-02-06 | At Loss |
| 2024-04-11 | At Loss | 2024-02-05 | At Loss |
| 2024-04-10 | At Loss | 2024-02-04 | At Loss |
| 2024-04-09 | At Loss | 2024-02-01 | At Loss |
| 2024-04-08 | At Loss | 2024-01-31 | At Loss |
| 2024-04-04 | At Loss | 2024-01-30 | At Loss |
| 2024-04-03 | At Loss | 2024-01-29 | At Loss |
| 2024-04-02 | At Loss | 2024-01-28 | At Loss |
| 2024-04-01 | At Loss | 2024-01-25 | At Loss |
| 2024-03-31 | At Loss | 2024-01-24 | At Loss |
| 2024-03-28 | At Loss | 2024-01-23 | At Loss |
| 2024-03-27 | At Loss | 2024-01-22 | At Loss |
| 2024-03-26 | At Loss | 2024-01-21 | At Loss |
| 2024-03-25 | At Loss | 2024-01-18 | At Loss |
| 2024-03-21 | At Loss | 2024-01-17 | At Loss |
| 2024-03-20 | At Loss | 2024-01-16 | At Loss |
| 2024-03-19 | At Loss | 2024-01-15 | At Loss |
| 2024-03-18 | At Loss | 2024-01-14 | At Loss |
| 2024-03-17 | At Loss | 2024-01-11 | At Loss |
| 2024-03-14 | At Loss | 2024-01-10 | At Loss |
| 2024-03-13 | At Loss | 2024-01-09 | At Loss |
Nextage Therapeutics Ltd (XTAE:NXTG) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Nextage Therapeutics Ltd
ISIN : IL0004330119
Compare
Compare
Traded in other countries / regions
NXTG.Israel IPO Date
1993-05-27Description
Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers